TGA warns against advertising mLs and units pricing
12 Aug 2019
The Therapeutic Goods Administration (TGA) has warned doctors against advertising a price per ‘units’ or ‘mLs’ for cosmetic injections.
The warnings came in letters sent to individual doctors following complaints made to the TGA. The letters stated that such pricing “makes an indirect reference to a Schedule 4 (Prescription Only) substance as it is not possible to purchase units of a service”.
The letter further stated:
“Advertisements for cosmetic services MUST NOT specify trade names of products (e.g., Belkyra) containing Schedule 4 substances or ingredients (e.g., deoxycholic acid) that are Schedule 4 substances, or make indirect reference to Schedule 4 substances from which they can be identified as this is a breach of the Act.”
Guidance on legal obligations when advertising therapeutic goods can be found on the TGA’s advertising hub.
Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Doctors' Health and Wellbeing with Dr Andrew Czuchwick
Specialist Anaesthetist Dr Andrew Czuchwicki discusses doctors’ health and wellbeing, sharing his personal experiences through his journey to specialisation.
11 Apr 2019
Doctor Health and Wellbeing
Writer, doctor and Churchill Fellow, Dr Benjamin Veness discusses a subject he is passionate about – doctor health and wellbeing. Because doctors need to take care of themselves too.
11 Apr 2019
How to Respond to a Complaint
Even a complaint that may seem trivial is important to the patient. MDA national Medico-legal Adviser and practicing GP, Dr Jane Deacon, discusses how to respond to a complaint.
11 Apr 2019
